Form D · Other Technology

TearScience, Inc.

Morrisville, NC · CIK 0001333252

Offering snapshot reported Apr 14, 2016 · SEC filing

Reported sold
$19.2M
Offering amount: $29.2M
Investors reported
14
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 31, 2016
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 14, 2016Initial$19,225,391No comparison14SEC filing
May 17, 2010Initial$39,644,353No comparison12SEC filing
Sep 24, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Jan 3, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Jul 13, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-261352

Source: Form D, filed Apr 14, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Joe Boorady Director, Executive
Joel Cutler Director
Todd Davis Director
Manoj George Executive
Donald Korb Director
Jim Largent Director
Abhijeet Lele Director
Joe Mandato Director
Geoff Pardo Director
Matthew Rieke Director
Immanuel Thangaraj Director
Nicole Wicker Executive
Timothy R. Willis Director, Executive

Issuer details

Industry: Other Technology (See others in industry)

Address:
5151 Mc Crimmon Parkway Suite 250
Morrisville, NC, 27560